go to home page

Limor Dori / Education in Science and Technology, Molecular Biochemistry

BA in Molecular Biochemistry and BSc in Science Education (Chemistry) at the Technion.

MSc in Medical Sciences from the Faculty of Medicine at the Technion, under the supervision of Nobel Prize Laureate Prof. Aaron Ciechanover.
M.B.A. from the Faculty of Industrial Engineering & Management at the Technion.

Participated in the Technion Excellence Program: 1998 – 2001.

Limor first engaged in research during the second semester of her studies, in Physical Organic Chemistry in the laboratory of Prof. Yoav Eichen from the Faculty of Chemistry, in the field of Photoinduced proton-transfer (PT) processes.

In the summer following her second year at the Technion, she spent almost 3 months at MIT in Boston at a Cell Biology Laboratory, under the supervision of Prof. Monty Krieger, Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts and in collaboration with the laboratory of Prof. Tomas Kirchhausen, Department of Cell Biology and Institute of Chemistry and Cell Biology, Harvard Medical School, Longwood, Massachusetts.


* Nieland, T., Penman, M., Dori, L., Kirchhausen, T., and Krieger, M. (2002) Discovery of chemical inhibitors of the selective transfer of lipids mediated by the HDL receptor SR-BI.Proc. Natl. Acad. Sci. USA. 99, 15422-15427.

* Dori, L. (2004) Mechanism of protein degradation mediated via conjugation of ubiquitin to the N-terminal residue of the target protein substrates. M.Sc. Thesis, Faculty of Medicine, Technion, Israel Institute of Technology.


Recommendation to Program participants: "The program has many advantages and enables you to experience your studies in any special way you choose to. Its reputation in the Technion and outside of it will help you in future career advancement, be it in academia or industry."


Limor worked at Teva's Global Generic R&D Regulatory Affairs Department and has 4 years of global regulatory experience in submission of new generic drug applications to the European and Canadian health authorities. She also became a Team Leader in this role.

Later, she served as a Product Portfolio Manager for Teva's Latin American Markets, managing projects and choosing new products for Teva's Markets. She used her pharmaceutical R&D experience and her MBA degree on a daily basis.

Today (2018): VP Clinical Operations at OncoHost.

Limor Dori